Scolaris Content Display Scolaris Content Display

Cochrane Database of Systematic Reviews

Pentoxifilina para la nefropatía diabética

Información

DOI:
https://doi.org/10.1002/14651858.CD006800.pub2Copiar DOI
Base de datos:
  1. Cochrane Database of Systematic Reviews
Versión publicada:
  1. 15 febrero 2012see what's new
Tipo:
  1. Intervention
Etapa:
  1. Review
Grupo Editorial Cochrane:

  1. Grupo Cochrane de Riñón y trasplante

Copyright:
  1. Copyright © 2013 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Cifras del artículo

Altmetric:

Citado por:

Citado 0 veces por enlace Crossref Cited-by

Contraer

Autores

  • Dan Shan

    Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, China

  • Hong Mei Wu

    Correspondencia a: Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, China

    [email protected]

    [email protected]

  • Qi Yuan Yuan

    Intensive Care Department, No.5 People's Hospital of Chengdu, Chengdu, China

  • Jun Li

    Department of Geriatrics, West China Hospital, Sichuan University, Chengdu, China

  • Rong Le Zhou

    Department of Ophthalmology, Xi'an No.4 Hospital, Xi'an JiaoTong University, Xi'an, China

  • Guan J Liu

    Chinese Cochrane Centre, Chinese Evidence‐Based Medicine Centre, West China Hospital, Sichuan University, Chengdu, China

Contributions of authors

  • DS: Writing the draft review

  • HMW: Search strategy development, resolution of disagreements, data analysis, protocol and review writing

  • QYY: Study assessment, data extraction and entry

  • RLZ: Study assessment, data extraction and entry

  • JL: Methodological and clinical consultancy

  • GJL: Statistical and methodological consultancy.

Sources of support

Internal sources

  • Department of Geriatrics, West China Hospital, SiChuan University, China.

External sources

  • None, Not specified.

Declarations of interest

  • Dan Shan: None known

  • Hong Mei Wu: None known

  • Qi Yuan Yuan: None known

  • Jun Li: None known

  • Rong Le Zhou: None known

  • Guan J Liu: None known

Acknowledgements

  • We would like to thank Narelle Willis, Leslee Edwards and Gail Higgins of the Cochrane Renal Group for their help in developing the search strategy, providing relevant trials and helpful comments.

  • We would like to thank the referees for their comments and feedback during the preparation of this review.

Version history

Published

Title

Stage

Authors

Version

2012 Feb 15

Pentoxifylline for diabetic kidney disease

Review

Dan Shan, Hong Mei Wu, Qi Yuan Yuan, Jun Li, Rong Le Zhou, Guan J Liu

https://doi.org/10.1002/14651858.CD006800.pub2

2007 Oct 17

Pentoxifylline for diabetic kidney disease

Protocol

Hong Mei Wu, Qi Yuan Yuan, Rong Le Zhou, Jun Li, Guan Jian Liu

https://doi.org/10.1002/14651858.CD006800

Differences between protocol and review

The risk of bias assessment tool has been used in place of the quality assessment checklist in accordance with the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011).

Notes

Data in Characteristics of included studies has been amended.

  • Harmankaya 2003 – Pentoxifylline  600 mg/d (NOT 4 times daily) // lisinopril 10 mg/d (NOT 4 times daily)

  • Navarro 1999a – Pentoxifylline  400 mg/d (NOT 4 times daily)

  • Pang 2003 – Pentoxifylline  100 mg/d (NOT 4 times daily)

  • Pantoja 2003 – Pentoxifylline 400 mg/d (NOT 4 times daily)